All news

(Image: Getty/Magicmine)

Insmed gets US approval for inhaled antibiotic

By Ben Hargreaves

Insmed has become the first company to receive approval through the limited population pathway for antibacterial and antifungal drugs set up by the US FDA in 2016.

(Image: Getty/wildpixel)

Delays at MSD’s CMO prompt Sinemet shortage

By Flora Southey

MSD has warned regulators to expect a shortage of its Parkinson’s medicine, Sinemet, due to production constraints at a contract manufacturer’s facility.